Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Limited C.TFS

"Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use."


CSE:TFS - Post by User

Comment by onepointsixoneon Jan 16, 2018 10:44pm
95 Views
Post# 27373801

RE:RE:RE:RE:RE:Do the math

RE:RE:RE:RE:RE:Do the mathThank you for directing me to the quarterly report. Please see the statement (c), as it confuses me and perhaps you can explain something to me. Here it is:

(c) Canntab would then amalgamate with Telferscot, recieving 4 post-consolidated Telferscot shares for each existing Canntab share, or about 23,852,000 post-consolidated shares, representing appxomately 97.3% of the share float of the combined entity

I think this might be an error on the part of the company. How exactly do you get 23,852,000 post consolidated shares, when you get those shares by consolidating the pre-consolidated TFS shares at a rate of 200:1. There are only 114M pre-consolidated shares. So you should get around 575,000. Isn't that right? Where do the 23.8M shares come from?

In any event, if you take out the middle part of (c),  you will see it says that Canntab will receive consideration representing 97.3% of the share float of the company. This means that the current TFS shareholders will have 2.7% of the company's value after the deal, split among 114M TFS shares that are curently held. 
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse